Nsclc stage iiib Clinical Trials
Conditions / Nsclc stage iiib
Delta Trials records 16 clinical trials for Nsclc stage iiib in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 130 study locations around the world. An additional 12 trials are active but not currently open for enrollment. Since 2020, 2 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
16
Total Trials
2
Recruiting
2
Completed
12
Other Active
2
Terminated since 2020
130
Study Locations
Browse by location (130 total)
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Hong Kong, Hong Kong 3 trialsAll trials in Hong Kong, Hong Kong
- Valencia, Spain 2 trialsAll trials in Valencia, Spain
- Barcelona, Spain 2 trialsAll trials in Barcelona, Spain
- Heidelberg, Germany 2 trialsAll trials in Heidelberg, Germany
- Lyon, France 2 trialsAll trials in Lyon, France
- Seattle, United States 2 trialsAll trials in Seattle, United States
- Paris, France 2 trialsAll trials in Paris, France
- Beijing, China 2 trialsAll trials in Beijing, China
- Marseille, France 2 trialsAll trials in Marseille, France
- Madrid, Spain 2 trialsAll trials in Madrid, Spain
- Málaga, Spain 2 trialsAll trials in Málaga, Spain
- Málaga, Spain 2 trialsAll trials in Málaga, Spain
- Toulouse, France 2 trialsAll trials in Toulouse, France
- Pittsburgh, United States 2 trialsAll trials in Pittsburgh, United States
- Essen, Germany 2 trialsAll trials in Essen, Germany
- Busan, South Korea 2 trialsAll trials in Busan, South Korea
- Paris, France 2 trialsAll trials in Paris, France
- Frankfurt, Germany 1 trialAll trials in Frankfurt, Germany
- Rennes, France 1 trialAll trials in Rennes, France